Karlin Daniel insider trades
Karlin Daniel has filed 34 Form 4s with the SEC that we hold, all for Definium Therapeutics, Inc. (DFTX), as Chief Medical Officer, Director. Across all of them we count 0 purchases worth $0 and 28 sales worth $1.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($1.1M). The largest single trade was a sale of 10,035 shares of Definium Therapeutics, Inc. worth $451.9K, dated 2026-06-25. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-03-01 and the latest 2026-09-29.
Definium Therapeutics, Inc. (DFTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-25 | S, sale reported on Form 4 | 8,242 | $6.3K | 2022-05-26 |
| 2022-05-27 | S, sale reported on Form 4 | 9,555 | $7.8K | 2022-05-31 |
| 2022-06-27 | S, sale reported on Form 4 | 26,238 | $18.4K | 2022-06-28 |
| 2022-07-25 | S, sale reported on Form 4 | 8,361 | $5.8K | 2022-07-27 |
| 2022-07-27 | S, sale reported on Form 4 | 9,856 | $6.8K | 2022-07-27 |
| 2022-08-31 | S, sale reported on Form 4 | 1,204 | $14.1K | 2022-09-01 |
| 2022-09-26 | S, sale reported on Form 4 | 565 | $3.1K | 2022-09-27 |
| 2022-09-27 | S, sale reported on Form 4 | 640 | $3.8K | 2022-09-27 |
| 2022-10-25 | S, sale reported on Form 4 | 541 | $1.5K | 2022-10-27 |
| 2022-10-27 | S, sale reported on Form 4 | 644 | $1.9K | 2022-10-27 |
| 2022-12-21 | S, sale reported on Form 4 | 1,211 | $3.3K | 2022-12-22 |
| 2023-03-01 | S, sale reported on Form 4 | 3,577 | $12.6K | 2023-03-02 |
| 2023-06-27 | S, sale reported on Form 4 | 3,820 | $12.2K | 2023-06-27 |
| 2023-06-27 | S, sale reported on Form 4 | 2,963 | $9.5K | 2023-06-27 |
| 2023-09-25 | S, sale reported on Form 4 | 3,678 | $13.1K | 2023-09-25 |
| 2023-09-25 | S, sale reported on Form 4 | 3,240 | $11.6K | 2023-09-25 |
| 2023-12-26 | S, sale reported on Form 4 | 6,774 | $24.6K | 2023-12-26 |
| 2024-03-25 | S, sale reported on Form 4 | 6,578 | $62.5K | 2024-03-26 |
| 2024-06-25 | S, sale reported on Form 4 | 6,925 | $50.0K | 2024-06-25 |
| 2024-09-25 | S, sale reported on Form 4 | 6,871 | $41.1K | 2024-09-25 |
| 2024-12-26 | S, sale reported on Form 4 | 6,643 | $49.4K | 2024-12-27 |
| 2025-03-25 | S, sale reported on Form 4 | 6,836 | $46.1K | 2025-03-26 |
| 2025-06-25 | S, sale reported on Form 4 | 7,848 | $53.4K | 2025-06-26 |
| 2025-09-25 | S, sale reported on Form 4 | 7,704 | $75.3K | 2025-09-26 |
| 2025-12-26 | S, sale reported on Form 4 | 5,600 | $73.6K | 2025-12-29 |
| 2026-03-25 | S, sale reported on Form 4 | 8,018 | $148.1K | 2026-03-26 |
| 2026-06-25 | S, sale reported on Form 4 | 10,035 | $451.9K | 2026-06-26 |
| 2026-09-25 | S, sale reported on Form 4 | 10,853 | $396.9K | 2026-09-29 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1897618) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms